$ALHC

Alignment Misses Q2 EPS Estimates

Stock falls 12% in after-hours trading Shares in Alignment Healthcare fell 12% in after-hours trading after reporting second quarter results. Orange-based Alignment, a Medicare Advantage provider for seniors, reported earnings per share (EPS) of 17 cents, missing the 20-cent consensus estimate, according to the TheFly.com. The company’s third-quarter revenue outlook of $1.3 billion to $1.32 billion also came in at the low end of Wall Street estimates.

Original reporting
Published Jul 31, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 12:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alignment Misses Q2 EPS Estimates — source image
Decision brief

The 30-second read

$ALHCBearishHigh
01

Why it matters

A miss versus consensus and a low-end revenue guide are likely to drive estimate cuts and near-term positioning changes for ALHC.

02

Market read

Traders have a fresh earnings and guidance datapoint driving an immediate after-hours repricing in ALHC.

03

What to watch

The article does not include margin, membership, or medical cost trend details that could offset the EPS miss and change the true earnings power.

Relevance 9/10Novelty 8/10Timing: after-hours today, immediately following Q2 results and Q3 outlook

Background

Alignment Healthcare is a Medicare Advantage provider; the article reports its Q2 EPS and Q3 revenue outlook.

Company-level read

Ticker impact

$ALHCBearishHigh confidence
Context

Alignment Healthcare shares fell 12% after hours after Q2 EPS missed (17 cents vs 20-cent consensus) and revenue outlook was at the low end.

Expected impact

Bearish bias for the next session, with elevated volatility as traders reprice Q3 revenue expectations.

Evidence & confidence

The article cites a specific EPS miss, a low-end revenue outlook, and an immediate after-hours selloff of about 12%.

Market effects

Medicare Advantage providers may see read-across selling if guidance quality is questioned, though this is single-name specific.

Limited to the company and its investor base; no broader regional catalyst described.

Low, as the event is company-specific and not tied to macro or cross-border developments.

Counterpoint

The stock drop may be overdone if the low-end revenue outlook still reflects seasonality or temporary utilization timing rather than structural deterioration.

Key entities

  • Alignment Healthcare

    Medicare Advantage provider whose Q2 EPS missed consensus and whose Q3 revenue outlook was at the low end.

Related articles

$ALHCMed

Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending?

Alignment Healthcare (ALHC) reported Q2 EPS of 17 cents, up from 7 cents a year earlier, with revenue rising 31.6% to $1.34B and beating consensus. Membership reached about 294,100. The company raised 2026 guidance to $5.195B-$5.225B revenue and 298,000-301,000 membership, but expects lower Q3 adjusted EBITDA ($20M-$30M) due to added clinical, AI and expansion spending.

$ALHCMed

Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation Into Potential Securities Law Violations

Kaplan Fox said a former Alignment Healthcare executive filed a whistleblower complaint alleging accounting irregularities that allegedly inflated reported and projected results, including Adjusted EBITDA, and misclassified operating expenses as capital expenditures. After the July 8, 2026 report, ALHC shares fell $4.02, or 16.7%, to close at $20.03, according to the article.

$ALHCMed

Alignment Healthcare (ALHC) Stock Trades Down, Here Is Why

Alignment Healthcare (ALHC) shares fell 14.8% after the company said it will reinvest profits, lowering expected second-half 2026 earnings. On its Q2 2026 call, management raised full-year revenue guidance but expects only about 30% of adjusted EBITDA in the second half, versus 40% a year earlier, due to investment timing.

$ALHCHighAI 9/10

Alignment Healthcare (ALHC) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - John E. Kao Chief Financial Officer - James Head TAKEAWAYS Health Plan Membership -- 294,000 members, representing 31% growth year over year. Total Revenue -- $1.3 billion, an increase of 32% year over year driven by membership growth. Adjusted MBR -- 86.3%, an improvement of 40 basis points year over year and the lowest since the company went public.

$ALHCMedAI 8/10

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops

Health insurance company Alignment Healthcare (NASDAQ: ALHC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 31.6% year on year to $1.34 billion. The company expects next quarter’s revenue to be around $1.31 billion, close to analysts’ estimates. Its GAAP profit of $0.17 per share was 29.8% above analysts’ consensus estimates. Is now the time to buy Alignment Healthcare? Find out by accessing our full research report, it’s free.

$ALHCMedAI 8/10

Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs

Alignment Healthcare’s second quarter net income more than doubled to $36.6 million compared to the year ago period as costs of care for older adults in its Medicare Advantage plans eased. Like many of its rival health insurers, particularly those in the Medicare Advantage business, Alignment has been battling rising medical expenses from customers in its health plans.